DCF — PALISADES MEDICAL CENTER
Enterprise Value: $-107.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-107.3M
Enterprise Value
$-38.3M
PV of Cash Flows
$-69.0M
PV of Terminal Value
$-111.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $196.3M | $-4.3M | -2.0% | $-12.6M | $-11.5M |
| Year 2 | $202.2M | $-2.4M | -1.0% | $-11.0M | $-9.1M |
| Year 3 | $208.3M | $-0.4M | -0.0% | $-9.2M | $-6.9M |
| Year 4 | $214.5M | $0.7M | 0.0% | $-8.4M | $-5.8M |
| Year 5 | $220.9M | $1.2M | 1.0% | $-8.1M | $-5.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-107.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$190.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.026963619892628674
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5